ServiziMenu principaleHome
You are here:  > Educational Opportunities > Past events > 2022 > Basic Principles in Oncology Course
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

Basic Principles in Oncology Course

18 ESCO credits

27.10.2022  -  30.10.2022

Ljubljana, Slovenia


Oncology basics


Chairs: A. Eniu, CH – F.A. Peccatori, IT

ESO is proposing a new comprehensive course for oncology trainees in Europe intended to bridge the gap in education between courses for students and ESO’s well-known Masterclasses. The course aims to provide orientation to the guiding principles of multidisciplinary oncological management and life as a modern oncologist.

Although some of the principles underlying oncology practice are similar to those in other branches of medicine, sub-specialisation has reduced the exposure of medical students and junior residents to oncological concepts and practice. New oncology trainees face a number of specific challenges. These include navigation of an extensive curriculum with no clear starting point, a rapidly evolving clinical landscape, and increasing clinical demands. During training, residents must also strategically plan their careers, manage any academic focus, and maintain a healthy work-life balance.

Learning Outcomes

  • Update on basic principles in etiology and epidemiology
  • Update on basic cancer genetics, staging and imaging
  • Update on basic surgical oncology and pathology
  • Update on basic radiology and chemotherapy
  • Intro to paediatric oncology
  • Intro to tumour board and patient issues: communication, supportive and palliative care
  • Intro to clinical trials and paper appraisal



The official language will be English. No translation will be available.


The Basic Principles of Oncology Course has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

It has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 20 European CME credits (ECMEC®s).

Each medical specialist should claim only those credits that he/she actually spent in the educational activity.

The EACCME® is an institution of the European Union of Medical Specialists (UEMS), www.uems.eu

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credits to AMA credits can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC® credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.


Attendance is limited to 80 participants and admittance is by competitive application only. Priority will be given to applicants who have attended an ESO-ESMO course for medical students or the ESO-ESSO-ESTRO course for medical students.

Successful applicants are granted free registration.
Accommodation at the course venue for arrival on Thursday 27 October and departure on Sunday 30 October will be provided to participants not residing in the Ljubljana area.


Dolores Knupfer
European School of Oncology (ESO)
Piazza Indipendenza 2
6500 Bellinzona
ph +41 91 820 09 52
e-mail: dknupfer@eso.net

In partnership with
Endorsed by


Ideal candidate:

  • 1-3 years oncology training

Interested candidates should apply online providing:

  • CV (template provided) with the list of publications (if the list of publication is not provided, it will be assumed that no articles have been published)
  • Motivation letter
  • Support letter from mentor or head of department



27 October

13:45Welcome address and general introduction
Alexandru Eniu, CH - Fedro Alessandro Peccatori, IT
14:00Principles of cancer etiology and epidemiology
Claudia Allemani , UK
14:30The hallmarks of cancer:Perspectives for cancer medicine
Douglas Hanahan, CH
15:00Principles of cancer genetics
Sheila Unger, CH
15:30Coffee break
16:00Basic cancer pathology
Giancarlo Pruneri, IT
16:30Basic principles of imaging in cancer assesment
Petra Steyerova, CZ
17:00Principles of staging systems
Jasna But Hadžic, SI
17:30The art of being an oncologist: a humanistic view
Franco Cavalli, CH
19:30Welcome Dinner

28 October

8:30The validity of serum tumor markers in oncology
Erika Matos, SI
9:00Molecular oncology: Towards precision medicine
Assma Ben Aissa, CH
9:30Principles of patient assessment
Ian Tannock, CA
10:00Principles of surgical oncology
Isabel T. Rubio, ES
10:30Coffee break
11:00Principles of radiotherapy: Basic physics and radiobiology
Primoz Strojan, SI
11:30Planning of radiotherapy, techniques and side effects
Rodica Anghel, RO
12:00Principles of systemic therapy (chemotherapy/hormonal therapy/ targeted agents)
Filippo De Braud, IT
12:30Basic principles of chemotherapy with toxicity
Giuseppe Curigliano, IT
14:00Basic principles of targeted therapies with toxicity
Tanja Cufer, SI
14:30Basic principles of immunotherapy with toxicity
Filippo De Braud, IT
15:00Coffee break
15:30Principles of AYA oncology
Stefan Bielack, DE
16:00Clinical case presentation and discussion
Giuseppe Curigliano, IT - Laurentia Nicoleta Gales, RO - Giancarlo Pruneri, IT - Primoz Strojan, SI
19:30Free Evening

29 October

8:30Basic principles of endocrine therapy with toxicity
Bostjan Seruga, SI
9:00Multidisciplinary care and tumor boards
Olivia Pagani, CH
9:30Cancer in the elderly
Matti Aapro, CH
10:00Oncological emergencies
Matteo Lambertini, IT
10:30Coffee break
11:00Infections in cancer patients, including COVID
Matteo Lambertini, IT
11:30Paraneoplastic syndromes
Erika Matos, SI
12:00Survivorship issues in cancer patients
Olivia Pagani, CH
12:30Principles of supportive care in cancer patients
Snezana Bosnjak, RS
13:00Principles of palliative care in cancer patients
Florian Scotté, FR
14:30Availability and rational use  of anti-cancer therapies (priorities or access to drugs)
Alexandru Eniu, CH
15:00Clinical case presentation and discussion
Giuseppe Curigliano, IT - Matteo Lambertini, IT - Erika Matos, SI - Florian Scotté, FR
16:30Coffee break
17:00Principles of communication with the cancer patients
Luzia Travado, PT
17:30Introduction to clinical trials
Tanja Cufer, SI
18:00Critical appraisal of papers
Ian Tannock, CA
18:30Free Evening

30 October

8:30The future of oncology - round table discussion
Claudia Allemani , UK - Tanja Cufer, SI - Alexandru Eniu, CH - Bostjan Seruga, SI
9:15Career planning and opportunities - round table discussion
Tanja Cufer, SI - Bostjan Seruga, SI - Ian Tannock, CA - Janez Zgajnar, SI
10:00Coffee break
10:30Self-assessment test
11:30Closing remarks and awards


Matti Aapro, Clinique de Genolier, Genolier Cancer Center, Genolier, CH
Claudia Allemani, London School of Hygiene and Tropical Medicine, Department of Non-Communicable Disease Epidemiology, London, UK
Rodica Anghel, Institute of Oncology "Prof. Dr. Al Trestioreanu", -, Bucharest, RO
Assma Ben Aissa, Geneva University Hospital, Oncology Department, Geneva, CH
Stefan Bielack, Klinikum Stuttgart - Olgahospital, Dept. of Pediatric Oncology, Hematology, Immunology Dpt., Stuttgart, DE
Snezana Bosnjak, Institute of Oncology and Radiology of Serbia, Supportive Oncology & Palliative Care Dpt., Belgrade, RS
Jasna But Hadžic, University of Ljubljana, Oncology and Radiotherapy Dept., Ljubljana, SI
Franco Cavalli, Oncology Institute of Southern Switzerland, Ufficio Prof. Cavalli, Bellinzona, CH
Tanja Cufer, University of Ljubljana, Medical Faculty, Ljubljana, SI
Giuseppe Curigliano, European Institute of Oncology / University of Milan, New Drugs for Innovative Therapies Division, Milano, IT
Filippo De Braud, University of Milan, Milan, IT
Alexandru Eniu, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Laurentia Nicoleta Gales, Institutul Oncologic „Prof. Dr. Alexandru Trestioreanu", Oncology Dept., Bucharest, RO
Douglas Hanahan, ISREC- Swiss Institute for Experimental Cancer, School of Life Sciences, Lausanne, CH
Matteo Lambertini, Policlinico San Martino Hospital – University of Genoa, Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, Genoa, IT
Erika Matos, Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, SI
Olivia Pagani, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Fedro Alessandro Peccatori, European Institute of Oncology, Dept. of Fertility and Procreation in Oncology, Milano, IT
Giancarlo Pruneri, National Cancer Institute, IRCCS Foundation, Pathology Dpt., Milano, IT
Isabel T. Rubio, Clínica Universidad de Navarra, Breast Surgical Oncology Dpt., Madrid, ES
Florian Scotté, Institute Gustave Roussy, Medical Oncology and supportive care department, Villejuif, FR
Bostjan Seruga, Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, SI
Petra Steyerova, General University Hospital Prague, Clinic of Radiology, Breast Cancer screening and diagnostic center, Prague 2, CZ
Primoz Strojan, Institute of Oncology, Dept.of Radiation Oncology, Ljubljana, SI
Ian Tannock, Princess Margaret Hospital, Dept. of Oncology and Hematology, Toronto, CA
Luzia Travado, Champalimaud Foundation, Champalimaud Centre For the Unknown, Lisbon, PT
Sheila Unger, University Hospital Centre Vaudois, Genetic Medicine Department, Lausanne, CH
Janez Zgajnar, Institute of Oncology Ljubljana, Dept. of Surgical Oncology, Ljubljana, SI